Albireo is a clinical-stage biopharmaceutical company focused on the development and potential commercialization of novel bile acid modulators to treat orphan paediatric liver diseases and other liver or gastrointestinal diseases and disorders. We have deep expertise in bile acid biology and a pipeline of clinical and nonclinical programs.
Odevixibat is a potent and selective inhibitor of the ileal bile acid transporter (IBAT), sometimes also referred to as the apical sodium dependent bile acid transporter (ASBT), that has minimal systemic exposure at therapeutic doses and acts locally in the gut.
Odevixibat has the potential to become the first approved pharmacologic treatment for patients with PFIC. The Company intends to complete regulatory filings in the EU and in the U.S. no later than early 2021, in anticipation of potential regulatory approval, issuance of a rare pediatric disease priority review voucher and launch in the second half of 2021, if approved. The Company also plans to initiate a pivotal Phase 3 trial of odevixibat in Alagille syndrome by the end of 2020, and to continue enrolling patients in the BOLD pivotal Phase 3 trial of odevixibat in biliary atresia. Albireo continues to progress its pipeline and expects to complete IND-enabling studies for a new preclinical candidate this year.
The U.S. Food and Drug Administration (FDA) has granted to the odevixibat PFIC program or elements of it fast track, rare paediatric disease and orphan drug designations. The European Medicines Agency (EMA) has granted odevixibat orphan designation, as well as access to the PRIority MEdicines (PRIME) scheme for the treatment of PFIC. Its Paediatric Committee has agreed to Albireo's odevixibat Pediatric Investigation Plan for PFIC. Both FDA and EMA also have granted orphan drug designation to odevixibat for the treatment of Alagille syndrome and primary biliary cholangitis. Albireo will commercialise Odevixibat in the US, Europe & Canada and will partner in remaining regions.
Job Title: Area Sales Director - West Coast
Reports To: Kevin Springman – President, Americas
Location: Boston, MA
You will ensure sales forecasts and operational budgets are met or exceeded within the therapeutic area at a regional level by inspiring ownership, accountability, initiative, and engagement within the entire team by regularly communicating Albireo’s vision, business objectives and performance outcomes.
Key Duties and Responsibilities:
You will focus the team on delivering a few high-impact opportunities by identifying issues and implementing customer-specific approaches based upon their needs and preferences.
You will accomplish this by using robust analytical rigor to frame situations and incorporate new perspectives and ideas.
You will anticipate and remove obstacles so that your team’s can deliver results and succeed.
You will establish business objectives, assesses performance, and addresses skill development for direct reports to ensure appropriate product portfolio management, including opportunities for career development by investing in long-term development of others through mentoring, coaching and continuous feedback.
You will lead and influence a team of Health System Directors through modeling and coaching to Albireo’s leadership capabilities by creating a climate of trust so team members can act decisively by clarifying roles/responsibilities and establishing boundaries of decision-making.
You will help your team align their business actions to the national/regional plans, so they can understand and evaluate the potential impact of external events on the organizational and regional strategies by accurately acknowledging both the broad environmental context of situations and the needs and motivations of others, so they know who they need to influence and why.
This role may also need to manage a few high priority accounts or Health Systems based on business opportunity or management discretion.
Minimum of 10 years of experience in pharmaceutical sales or healthcare, at least 5 years specifically with Health Systems
Leadership experience in Rare Disease sales, Health Systems and KOL development
Preference in working and leading a sales team in an institutional market (formulary, stocking, and protocol development).
Experience in leading Institutional directors (Hospital Health System Executives, Institutional Account Executives and Quality Institutional Account Managers)
Extensive knowledge of the Integrated Delivery Networks or Health System market
Demonstrated communication competencies
Ability to lead and develop Health System Directors
Experience in managing budgets
A valid driver’s license and safe driving record
Equal Opportunity Employer
All applicants should be legally entitled to work for any employer in the U.S.
Note to employment agencies: Please do not forward any agency resumes.